PHARMACOKINETICS OF CEFOTAXIME IN NEONATES

被引：29

作者：

BAIRDLAMBERT, J ^{[1
]}

DOYLE, PE ^{[1
]}

THOMAS, D ^{[1
]}

CVEJIC, M ^{[1
]}

BUCHANAN, N ^{[1
]}

机构：

[1] UNIV SYDNEY,WESTMEAD CTR,WESTMEAD,NSW 2145,AUSTRALIA

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1984年 / 13卷 / 05期

关键词：

D O I：

10.1093/jac/13.5.471

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：471 / 477

页数：7

共 19 条

[1] METABOLISM OF CEFOTAXIME IN ANIMALS AND MAN
CHAMBERLAIN, J
COOMBES, JD
DELL, D
FROMSON, JM
INGS, RJ
MACDONALD, CM
MCEWEN, J
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1980, 6 : 69 - 78
[2] TOXICOLOGY OF CEFOTAXIME IN COMPARISON TO OTHER CEPHALOSPORINS
DOERR, BI
GLOMOT, R
KIEF, H
KRAMER, M
SAKAGUCHI, T
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1980, 6 : 79 - 82
[3] EFFECT OF PRENATAL EXPOSURE TO BETAMETHASONE ON METRONIDAZOLE ELIMINATION IN PREMATURE-INFANTS
DOYLE, PE
JAGERROMAN, E
BAIRDLAMBERT, J
CVEJIC, M
BUCHANAN, N
[J]. JOURNAL OF PEDIATRICS, 1982, 101 (04) : 647 - 647
[4] PHARMACOKINETICS OF CEFOTAXIME IN NORMAL HUMAN VOLUNTEERS
ESMIEU, F
GUIBERT, J
ROSENKILDE, HC
HO, I
GO, AL
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1980, 6 : 83 - 92
[5] INCREASED THEOPHYLLINE METABOLISM IN PREMATURE-INFANTS AFTER PRENATAL BETAMETHASONE ADMINISTRATION
JAGERROMAN, E
DOYLE, PE
THOMAS, D
BAIRDLAMBERT, J
CVEJIC, M
BUCHANAN, N
[J]. DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1982, 5 (3-4): : 127 - 135
[6] KAFETZIS DA, 1982, J PEDIATR-US, V100, P483
[7] MAYER SE, 1980, PHARMACOL BASIS THER, P1
[8] PHARMACOKINETICS OF CEFOTAXIME IN NEWBORN-INFANTS
MCCRACKEN, GH
THRELKELD, NE
THOMAS, ML
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (04) : 683 - 684
[9] ANTI-BACTERIAL ACTIVITY OF CEFOTAXIME
MITSUHASHI, S
INOUE, M
MASUYOSHI, S
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1980, 6 : 37 - 46
[10] RENAL FUNCTIONS AND CLINICAL DISORDERS IN THE NEONATE
OH, W
[J]. CLINICS IN PERINATOLOGY, 1981, 8 (02) : 215 - 223

← 1 2 →